Abiopharma

🔍 Glenn Dylan (Director)

Company: Intellicheck, Inc. (IDN)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 3,577 shares of Common Stock, $.001 par value at $6.99 per share (Direct)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 88,764.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents restricted stock units granted to the Reporting Person on March 31, 2026 (the Grant Date), which convert to shares of Common Stock, par value $0.001, of Intellicheck, Inc. on a one-for-one basis, and which vested in full on the Grant Date.